General Information
Drug ID
DR00325
Drug Name
Acyclovir
Synonyms
2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension
Drug Type
Small molecular drug
Indication Herpes simplex virus infection [ICD11: 1F00] Approved [1]
Chickenpox [ICD11: 1.00E+90] Approved [1]
Shingles [ICD11: 1.00E+91] Approved [1]
Therapeutic Class
Antiviral Agents
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=135398513"></iframe>
3D MOL 2D MOL
Formula
C8H11N5O3
Canonical SMILES
C1=NC2=C(N1COCCO)N=C(NC2=O)N
InChI
InChI=1S/C8H11N5O3/c9-8-11-6-5(7(15)12-8)10-3-13(6)4-16-2-1-14/h3,14H,1-2,4H2,(H3,9,11,12,15)
InChIKey
MKUXAQIIEYXACX-UHFFFAOYSA-N
CAS Number
CAS 59277-89-3
Pharmaceutical Properties Molecular Weight 225.208 Topological Polar Surface Area 115
Heavy Atom Count 16 Rotatable Bond Count 4
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 5
PubChem CID
135398513
PubChem SID
10321108 , 10589392 , 11110742 , 11110743 , 11335360 , 11360599 , 11364633 , 11367195 , 11369757 , 11372947 , 11374028 , 11377919 , 11461571 , 11466114 , 11467234 , 11485202 , 11485687 , 11489379 , 11491689 , 11492040 , 11495553 , 11528717 , 12013356 , 14773677 , 15172245 , 15220533 , 17404601 , 1916590 , 24278078 , 24890562 , 25621755 , 26612492 , 26679648 , 26747423 , 26747424 , 502278 , 5344000 , 5344001 , 594925 , 603044 , 6855606 , 7847289 , 7885662 , 794369 , 7978637 , 8150001 , 8151390 , 829893 , 855732 , 9029
ChEBI ID
ChEBI:2453
TTD Drug ID
D0B5MP
DT(s) Transporting This Drug ASCT2 Transporter Info Alanine/serine/cysteine/threonine transporter 2 Substrate [2]
BCRP Transporter Info Breast cancer resistance protein Substrate [3]
MATE1 Transporter Info Multidrug and toxin extrusion protein 1 Substrate [4]
MATE2 Transporter Info Multidrug and toxin extrusion protein 2 Substrate [4]
MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [5]
OAT1 Transporter Info Organic anion transporter 1 Substrate [6]
OAT2 Transporter Info Organic anion transporter 2 Substrate [7]
OAT3 Transporter Info Organic anion transporter 3 Substrate [8]
OCT1 Transporter Info Organic cation transporter 1 Substrate [6]
Drug-Transporter Activity Data
Drug-Transporter Activity Data MATE1 Transporter Info Km = 2640 microM Human embryonic kidney cells (HEK293)-MATE1 [4]
MATE2 Transporter Info Km = 4320 microM Human embryonic kidney cells (HEK293)-MATE2K [4]
OAT1 Transporter Info Km = 839 microM Human embryonic kidney cells (HEK293)-OAT1 [8]
OAT1 Transporter Info Km = 342 microM Proximal tubule (S2) cells-OAT1 [6]
OAT3 Transporter Info Km = 772 microM Human embryonic kidney cells (HEK293)-OCT2 [8]
OCT1 Transporter Info Km = 151.2 microM Proximal tubule (S2) cells-OCT1 [6]
References
1 Acyclovir was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs. Curr Drug Targets Immune Endocr Metabol Disord. 2005 Dec;5(4):357-64.
3 Acyclovir is a substrate for the human breast cancer resistance protein (BCRP/ABCG2): implications for renal tubular transport and acyclovir-induced nephrotoxicity. Can J Physiol Pharmacol. 2011 Sep;89(9):675-80.
4 Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. Biochem Pharmacol. 2007 Jul 15;74(2):359-71.
5 Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters. J Pharmacol Exp Ther. 2003 Aug;306(2):778-86.
6 Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002 Mar;300(3):918-24.
7 Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP. Mol Pharmacol. 2008 Apr;73(4):1151-8.
8 Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs. Drug Metab Dispos. 2012 Mar;40(3):617-24.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.